SlideShare a Scribd company logo
1 of 72
Xenobiotics Metabolism
CYP450
Dr. Rajender Kumar
P.G. Biochemistry
Pt. B.D.S.P.G.I.M.S. Rohtak
Introduction
 A xenobiotic is a foreign chemical substance found
within an organism that is not normally, naturally
produced by or expected to be present within that
organism. It can also cover substances which are
present in much higher concentrations than are usual
 Examples- Drugs, food additives, pollutants,
insecticides, chemical carcinogens etc
 They enter body mainly with food or as medications
 Three principal entries: intestine, lungs, skin
Entry of xenobiotic into cells
• Simple diffusion – lipophilic substances, depends on
concetration gradient (liver – freely permeable, big pores
in cell membrane, most affected in poisoning)
• Facilitated diffusion – transporters
• Active transport – primary, secondary
• Endocytosis
• xenobiotics structurally similar with physiological
substrates can utilize all available transport systems
Excretion of xenobiotics from cell
• primary active transport – needs energy: ATP hydrolysis
• special ATP-ases called ABC (ATP binding cassettes)
localized in cell membranes, export xenobiotics from
cells into ECF
• MRP (multidrug resistance proteins) – in increased
expresion, they cause the resistance towards medicines
Excretion of xenobiotics from body
• chemically modified (more polar) xenobiotics are
excreted by urine, bile, stool, or sweat
• volatile substance by lungs
• excretion into human milk
• intestinal deconjugation and reabsorption
sometimes occur - enterohepatic circulation
Biotransformation and detoxification
Biotransformation is Conversion of lipophilic to water-
soluble chemicals catalyzed by enzymes in the liver
and other tissues
 In most cases, biotransformation lessens the toxicity
of xenobiotics
The term “detoxification” is sometimes used for
many of the reactions involved in the metabolism of
xenobiotics
Increasingly humans are subjected to exposure to various
foreign chemicals xenobiotics. Knowledge of the metabolism of
xenobiotics is basic to a rational understanding of
 pharmacology and therapeutics
 pharmacy
 toxicology
 management of cancer, and drug addiction
All these areas involve administration of, or exposure to,
xenobiotics
Biomedical importance
1. facilitates excretion: Converts lipophilic to
hydrophilic compounds
2. Detoxification/inactivation: converts
chemicals to less toxic forms
3. Metabolic activation: converts chemicals to
more toxic active forms or converts inactive
drug to its active form
Purpose of Biotransformation
Sites of biotransformation
• Liver
– Primary site! Rich in enzymes
– Acts on endogenous and exogenous compounds
• Extrahepatic metabolism sites
– Intestinal wall
• Sulfate conjugation
• Esterase and lipases - important in prodrug
metabolism
– Lungs, kidney, placenta, brain, skin, adrenal glands
Metabolism of Xenobiotics
phase 1
1. Hydroxylation
Monooxygenases or cytochrome P450s
Hydroxylation may terminate the action of a drug
2. deamination, dehalogenation,
desulfuration, epoxidation,
peroxygenation, and reduction, hydrolysis
• Purpose
– Introduction of polar functional groups in a molecules
♣ Increase a molecule’s polarity
♣ Does provide a site for phase II metabolism
Metabolism of Xenobiotics
Phase 2
conjugation with
glucuronic acid,
sulfate,
acetate,
glutathione,
methyl
or certain amino acids,
The overall purpose of phases II of metabolism of
xenobiotics is to increase their water solubility
(polarity) and thus excretion from the body
Xenobiotic-Metabolizing Enzymes
(XME)
Phase 1
• Cytochromes P450
• Flavin Containing Monooxygenase
• Epoxide Hydrolase
• Alcohol /Aldehyde Dehydrogenases
• Monoamine Oxidases
• Xanthine oxidase
Phase 2 “Transferases”
Sulfotransferases (ST)
UDP-glucuronosyltransferases (UGT)
Glutathione S-transferases (GST)
Cytochrome P450
• superfamily of heme enzymes (many isoforms) can
catalyze different reaction types, mainly hydroxylation
• Human:18 families, 43 subfamilies, 57 sequenced genes
• can be induced and inhibited
• occur in most tissues (except of muscles and erythrocytes)
• the highest amount in the liver (ER)
• exhibit genetic polymorphism (atypical biotransformations)
• Nomencleature:
CYP1A2
family subfamily individual member of that
subfamily
Location of Cytochrome P450
• They are present in highest amount in liver and small
intestine but are probably present in all tissues
• In liver and most other tissues, they are present mainly
in the membranes of the smooth endoplasmic
reticulum
• In the adrenal, they are found in mitochondria as well
as in the endoplasmic reticulum
• The various hydroxylases present in that organ play an
important role in cholesterol and steroid biosynthesis
Cytochrome P450
• At least six isoforms of cytochrome P450 are
present in the endoplasmic reticulum of human liver,
• acting on both xenobiotics and endogenous compounds
• P450 metabolizes certain widely used solvents and also
components found in tobacco smoke, many of which are
established carcinogens
• Most isoforms of cytochrome P450 are inducible
• Induction of cytochrome P450 has important clinical
implications, since it is a biochemical mechanism of
drug interaction
Cytochrome P450
Certain isoforms of cytochrome P450 (eg, CYP1A1) are
particularly involved in the metabolism of polycyclic
aromatic hydrocarbons (PAHs) and related
molecules
for this reason they were formerly called aromatic
hydrocarbon hydroxylases (AHHs)
This enzyme is important in the metabolism of PAHs
and in carcinogenesis produced by these agents
Cytochrome P450
Certain cytochrome P450s exist in polymorphic forms
(genetic isoforms), some of which exhibit low catalytic
activity
CYP2A6 involved in the metabolism of nicotine to conitine,
three alleles have been identified, a wild type and two null
or inactive alleles
Individuals with the null alleles, who have impaired
metabolism of nicotine, are apparently protected against
becoming tobacco- dependent smokers
because their blood and brain concentrations of nicotine
remain elevated longer
It has been speculated that inhibiting CYP2A6 may be a
novel way to help prevent and to treat smoking
Cytochrome P450
• some xenobiotics induce the synthesis of CYP – the
metabolic capacity of CYP is enhanced
• if administered inducer + drug, both metabolized by the
same CYP isoform and drug is metabolized faster, drug
is less effective
• some xenobiotics inhibit CYP
• the most common isoform CYP3A4 metabolizes more
than 120 different pharmaceutical drugs
• inhibitors of CYP3A4 are e.g. macrolide antibiotics,
grapefruit (furanocoumarins), ketoconazole
• if administered inhibitor + drug, increased drug level,
overdosing , side effects
Inducers and inhibitors of CYP450
cytochrome P450 contains three cofactors and two enzymes:
• NADPH+H+, FAD, heme
• NADPH:CYP reductase (separates 2 H  2 e- + 2H+) and
cytochrome P-450 hydroxylase
Lipids are also components of the cytochrome P450 system
The preferred lipid is phosphatidylcholine, which is the major
lipid found in membranes of the endoplasmic reticulum
Components of cytochrome P450
Mechanism of CYP hydroxylation
The formation of hydroxyl group
 monooxygenase: one O atom from O2 molecule is
incorporated into substrate between C and H (R-H → R-OH )
 The second O atom + 2H from NADPH+H+
give water
R-H + O2 + NADPH + H+
→ R-OH + H2O + NADP+
2 e-
+ 2 H+
Mechanism of CYP hydroxylation
PHASE I REACTIONS
• Hydroxylation is the chief reaction involved
• The responsible enzymes are called monooxygenases
and cytochrome P450s
• Hydroxylation by CYP450 occurs in endogenous and
exogenous substrates
• Endoplasmic reticulum: squalene, cholesterol, bile
acids, FA desaturation, prostaglandins, xenobiotics
• Mitochondria: steroidal hormones
hydroxylation
Example of hyroxylation
Flavin-containing Monooxygenase
•FAD-containing monooxygenases
(FMO) oxidize nucleophilic
nitrogen, sulfur and phosphorus
heteroatoms of a variety of
xenobiotics
• FMO’s are not inducible and are
constitutively expressed
•Can be inhibited by other
substrates
• Located in microsomal fraction of
liver, kidney, and lung
FMO
FAD
FMO
FADH2
NADP
+
FMO
FADHOOH
NADP+
FMO
FADHOH
NADP+
NADPH
+ H+
O2
X
XO
NADP+
H2O
FADHOOH is 4a-hydroperoxyflavin
FADHOH is 4a-hydroxyflavin
FMO
FAD
FMO Example Reactions
N
N
CH3
N
N
CH3
excretion
nicotine
O
N
O
CH3
H
N
O
CH3
OH
nicotine-1'-N-oxide
2-acetylaminofluorene (2-AAF)
caricnogen
N-hydroxy-2-AAF
FMO
FMO
Epoxides are highly reactive and mutagenic or carcinogenic
can form during Phase I (CYP/COX)
Epoxide hydrolase converting them into much less reactive
dihydrodiols
There are 5 distinct forms of EH in mammals:
1. Microsomal epoxide hydrolase (mEH)
2. Soluble epoxide hydrolase (sEH)
3. Cholesterol epoxide hydrolase
4. LTA4 hydrolase
5. Hepoxilin hydrolase
mEH and sEH hydrolyze xenobiotic epoxides while the latter 3
hydrolases act on endogenous substrates
Epoxides
Hydrolysis in plasma by esterases (suxamethonium
by cholinesterase)
Alcohol and aldehyde dehydrogenase in liver
cytosolic (ethanol)
Monoamine oxidase in mitochondria (tyramine,
noradrenaline, dopamine, amines)
Xanthine oxidase (6-mercaptopurine, uric acid
production)
Enzymes for particular substrates (tyrosine
hydroxylase, dopa-decarboxylase etc.)
Other (non-microsomal) Phase I reactions
RCH2NH2+O2+H2O2
RCHO+NH3+H2O
•MAO catalyze the oxidative deamination of monoamines
•Oxygen is used to remove an amine group from a molecule,
resulting in the corresponding aldehyde and ammonia
• MAO are found bound to the outer membrane of
mitochondria in most cell types in the body
•They belong to protein family of flavin containing amine
oxidoreductases
Non-Microsomal Oxidation Reactions
Hydrolytic Reactions
R1
R2
Name Susceptibility
to Hydrolysis
C O Ester Highest
C S Thioester
O O Carbonate
C N Amide
O N Carbamate
N N Ureide Lowest
Naming carbonyl - heteroatom groups
Hydrolyzes (adds water to) esters and amides and their
isosteres
Enzymes: Non-microsomal hydrolases
however amide hydrolysis appears to be mediated by liver
microsomal amidases, esterases, deacylases
R1 C R2
O
δ−
δ+
O CH3
CO2H
O
OH
CO2
H
CH3
O
OH
ASA
Acetylsalicylic Acid
esterase
PHASE II REACTIONS
CONJUGATIONS
Glucuronidation
• most frequent conjugation reaction.
• UDP-glucuronic acid (UDPGA) is the glucuronyl donor
• UDP-glucuronyl transferases (UGT), present in both the
endoplasmic reticulum(ER) and cytosol, are the catalysts
• Molecules such as 2-acetylaminofluorene (a carcinogen),
aniline, benzoic acid, meprobamate (a tranquilizer),
phenol, and many steroids are excreted as glucuronides
• The glucuronide may be attached to oxygen, nitrogen,
or sulfur groups of the substrates
Glucuronidation
Some alcohols, arylamines, and phenols are sulfated
other biologic sulfation reactions are sulfation of steroids,
glycosaminoglycans, glycolipids, and glycoproteins
The sulfate donor is adenosine 3-phosphate-5-
phosphosulfate (PAPS)
Leads to inactive water-soluble metabolites
Sulfation
Glutathione (γ-glutamyl-cysteinylglycine) is a tripeptide
consisting of glutamic acid, cysteine, and glycine
It detoxify electrophilic chemicals
Conjugation with Glutathione
The glutamyl and glycinyl groups belonging to
glutathione are removed by specific Enzymes
acetyl group (donated by acetyl- CoA) is added to the
amino group of the remaining cysteinyl moiety
The resulting compound is a mercapturic acid, a
conjugate of L acetylcysteine, which is then excreted in the
urine
Mechanism Conjugation with Glutathione
Reaction catalyzed by acetyltransferases present in the
cytosol of various tissues, particularly liver
Important for drugs with primary amino groups
The drug isoniazid, used in the treatment of tuberculosis,
is subject to acetylation
Acetylation does NOT increase water solubility
Causes Detoxification or termination of drug activity
Acetylation
isoniazid
A few xenobiotics are subject to methylation by
methyltransferases
S-adenosylmethionine is methyl donor
Key for biosynthesis of many compounds Important in the
inactivation of physiologically active biogenic amines 
neurotransmitters norepinephrine, dopamine, serotonin,
histamine
Minor pathway in the metabolism of drugs
Methylation does NOT increase water solubility
Most methylated products are inactive
Methylation
• with glycine, taurine
• xenobiotics with -COOH groups are the substrates
• endogenous example: conjugated bile acids
Approximately 76% of aspirin is metabolized through amino
acid conjugation
Salicyluric acid, the glycine conjugate of salicyclic acid, is
the main metabolite of aspirin
Conjugation with amino acids
Peroxidases
RH + O2
PHS
R-OOH + X or XH
PHS
MOx
LOx
ROH + XO or X
R-OOH + carcinogen
PHS
MOx
LOx
active carcinogen
(ie. aflatoxin)
1. Prostaglandin H synthase (PHS, COX1,2) (brain, lung,
kidney, GI tract, urinary bladder)
2. Myeloperoxidase (MOx) (leukocytes)
3. Lactoperoxidase (LOx) (mammary gland)
Most oxidative biotransformations require reduced cofactors
NADPH and NADH, except for peroxidases that couple the
reduction of hydrogen peroxide and lipid hydroperoxides to
the oxidation of other substrates called cooxidation
Prostaglandin H synthase
COOH
arachidonic acid
O2 + O2
O
O
COOH
OOH
PGG2
cyclooxygenase
peroxidase
X or 2XH
XO or 2X + H2O
O
O
COOH
OH
PGH2
prostacyclinthromboxane A2prostaglandins
(PGD2, PGE2)
PHS (COX) has two catalytic activities:
1. a cyclooxygenase (COX) that converts
arachidonic acid to the cyclic endoperoxide-
hydroperoxide PGG2)
2. a peroxidase (that converts the
hydroperoxide to the corresponding alcohol
PGH2) which can result in the oxidation of
xenobiotics
3. COX-2 inhibitors include aspirin and ibuprofin
PHS can bioactivate carcinogens such as β-
napthylamine, a bladder carcinogen
NH2
PHS
NH
DNA
damage
Activation of prodrugs
CARCINOGENS
PAHs formed by:
- incomplete combustion of organic matter such as coal,
wood, oil, petrol and diesel
- coke production, vehicle and aircraft exhaust
- smoking cigarettes
- charbroiled meats
PAHs are also found in natural fuel deposits
A few PAHs are used to produce medicine, dyes, plastics, &
pesticides
Natural sources of PAHs include volcanoes and natural fires
Examples include Benzo(a)pyrene and Benzo(b)fluoranthene
PAH in environment
- radicals formed by pyrolysis of hydrocarbons between
500 and 800ºC in zone of flame with insufficient O2
- C1 and C2 fragments combine in reducing atmosphere
to form condensed aromatics
- on cooling, PAHs condense onto existing particles –
their distribution reflects their differing thermodynamic
stability in O2 deficient flame
Mechanism of formation during combustion
Source %
Heating, power production 51
Industrial producers 20
Incineration & open burning 28
Vehicles 1
B(a)P in foodstuffs μg/kg
Charcoal broiled steak 8
Margarine 1-36
Sausages 4-50
Roasted coffee 1-13
Toast 0.5
PAHs effects
•Some PAHs have been shown to be cancer causing
•Chronic Bronchitis
•Skin Problems
•Allergies
Fetus is at greater risk and susceptibility :
•Growth retardation
•Low birth weight
•Small head circumference
•Low IQ
•Damage DNA
•Disrupt endocrine systems, such as estrogen, thyroid, and
steroids
CYP/PHS
O
EH
HO
OH
CYP/PHS
HO
OH
O
benzo[a]pyrene (+) benzo[a]pyrene
7,8-oxide (-) benzo[a]pyrene
7,8-dihydrodiol
(+) benzo[a]pyrene
7,8-dihydrodiol-9,10-epoxide
ULTIMATE CARCINOGEN
HN
N
N
NO
HN
DNA
HO
OH
HO
BaP-N2
-dG DNA adduct
DNA
GST/GSH
OH
GS
inactive (excreted)
O
CYP/PHS
OH
OH
inactive
Phase II
Phase II and
excretion
PAHs metabolites
• The first reaction is an epoxidation. With benzo(a)pyrene,
the product is the corresponding 7,8-epoxide that, in turn, is
subject of epoxide hydrolases to form stereoisomeric
dihydrodiols
• These are converted further to the 7,8-dihydrodiol-9,10-
epoxide. The terminal oxidase is cytochrome P-450
(CYP1A1). The diol epoxide can exist in 4 stereoisomeric
forms of which the key carcinogenic product is
benzo(a)pyrene-r-7,t-8-diol-t-9,10-epoxide
• PAH epoxides can then be conjugated with GSH. This
conjugation is regarded as a true detoxification reaction and
is mediated by glutathione transferase (GSTM1)
PAHs metabolites
• The epoxides that are not conjugated with GSH are
converted into phenols and diols. These PAH
metabolites, however, are sometimes not sufficiently
polar to be excreted and are therefore conjugated with
glucuronic or sulfuric acids to enable excretion to
occur
• In addition to conjugation, the hydroxylated derivatives of
PAHs may undergo a number of oxidation and
hydroxylation reactions. These include the conversion
of phenols to phenol-epoxides and subsequently to
diphenols and triols, diols to tetrols and diol-epoxides,
and triols to triolepoxides and pentols
PAHs metabolites
Aflatoxin
Aflatoxins are naturally occurring mycotoxins that are produced
by many species of Aspergillus, a fungus.
They can be found on moldy peanuts, rice, corn and other crops.
Aflatoxin B1 is the most potent liver carcinogen.
Aspergillus fungus that procues aflatoxin Aspergillus fungus on corn
O
O
O
OO
OCH3
* *
isolated
e-
-rich double bond
aflatoxin
O
O
O
OO
OCH3
* *
O
ULTIMATE CARCINOGEN
CYP/PHS
DNA
NHN
N
N
O
NH2
DNA
O
O
O
OO
OCH3
HO
GST/GSH
O
O
O
OO
OCH3
* *GS
OH
EH
inactive (excreted)
O
O
O
OO
OCH3
* *HO
OH
* *
AFB1 N7-DNA
adduct
* electrophilic
some DNA activity
Epoxide hydrolase can detoxify aflatoxin-epoxide from binding to DNA, but still has some
mutagenic activity
Aflatoxin metabolism
N-Hydroxylation of AAF
N-Hydroxylation of AAF is the first metabolic step towards
the development of a carcinogenic agent
Further Metabolism of N-HydroxyAAF Produces Cancer
N-HydroxyAAF undergoes phase II metabolism to the ultimate
carcingogen. The glucuronide pathway is also involved in
carcinogenesis
Tobacco
• during cigarette burning?
• temperature about 900 o
C
• dried tobacco undergoes incomplete combustion
• nicotine partly passes to smoke, partly decomposes
• Nicotine: 0.9 mg/cig.
• Tar: 11 mg/cig.
Tobacco
Cigarette smoke contains
• free base of nicotine – binds to receptors in the brain
• CO – binds to hemoglobin to give carbonylhemoglobin
(tissue ischemia)
• nitrogen oxides – may generate reactive radical
species
• polycyclic aromatic hydrocarbons (PAH)(pyrene,
chrysene, benzo[a]pyrene …), main components of tar
• they can attack and damage DNA, carcinogens
• other substances (N2, CO2, HCN, CH4, esters …)
Tobacco
Toxic effects of xenobiotics
1. cell injury (cytotoxicity)
2. the reactive species of a xenobiotic may bind to a protein, altering
its antigenicity. The xenobiotic is said to act as a hapten
3. reactions of activated species of chemical carcinogens with DNA
are thought to be of great importance in chemical carcinogenesis
Factors that influence metabolism of
xenobiotics
• Age
– older people less efficient at metabolism
• Sex
– Linked to hormonal differences
• Heredity
– Genetic differences can influence amounts and
efficiency of metabolic enzymes
• Disease states
– Liver, cardiac, kidney disease
THANKS

More Related Content

What's hot (20)

Role of cytochrome p450 in toxicity
Role of cytochrome p450 in toxicityRole of cytochrome p450 in toxicity
Role of cytochrome p450 in toxicity
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 
Glucose transport
Glucose transportGlucose transport
Glucose transport
 
Drug excretion new
Drug excretion newDrug excretion new
Drug excretion new
 
Drug Metabolism and Related Drug Interactions
Drug Metabolism and Related Drug InteractionsDrug Metabolism and Related Drug Interactions
Drug Metabolism and Related Drug Interactions
 
Receptor tyrosine kinases.ppt
Receptor tyrosine kinases.pptReceptor tyrosine kinases.ppt
Receptor tyrosine kinases.ppt
 
Vijay biotransformation
Vijay biotransformationVijay biotransformation
Vijay biotransformation
 
Neurotransmitter - Dopamine
Neurotransmitter - DopamineNeurotransmitter - Dopamine
Neurotransmitter - Dopamine
 
Nitric oxide
Nitric oxideNitric oxide
Nitric oxide
 
Protein synthesis inhibitors
Protein synthesis inhibitorsProtein synthesis inhibitors
Protein synthesis inhibitors
 
XENOBIOTICS.pptx
XENOBIOTICS.pptxXENOBIOTICS.pptx
XENOBIOTICS.pptx
 
Secondary messengers system
Secondary messengers systemSecondary messengers system
Secondary messengers system
 
Autophagy
AutophagyAutophagy
Autophagy
 
cyp450 system
cyp450 systemcyp450 system
cyp450 system
 
Suicide inhibitors
Suicide inhibitorsSuicide inhibitors
Suicide inhibitors
 
CATABOLISM OF PURINE NUCLEOTIDES
CATABOLISM OF PURINE NUCLEOTIDESCATABOLISM OF PURINE NUCLEOTIDES
CATABOLISM OF PURINE NUCLEOTIDES
 
Glycine
GlycineGlycine
Glycine
 
Xenobiotic metabolism
Xenobiotic metabolismXenobiotic metabolism
Xenobiotic metabolism
 
Receptors
ReceptorsReceptors
Receptors
 
Biotransformation
BiotransformationBiotransformation
Biotransformation
 

Similar to CYP450 Xenobiotics Metabolism

Pharmacokinetics metabolism and excretion
Pharmacokinetics metabolism and excretionPharmacokinetics metabolism and excretion
Pharmacokinetics metabolism and excretionsumitmahato20
 
Metabolism and excretion
Metabolism and excretionMetabolism and excretion
Metabolism and excretionUrmila Aswar
 
Biotransfermation of drugs by harsha
Biotransfermation of drugs by harshaBiotransfermation of drugs by harsha
Biotransfermation of drugs by harshaSriharsha Rayam
 
metabolism and elemination.ppt
metabolism and elemination.pptmetabolism and elemination.ppt
metabolism and elemination.pptMamtanaagar1
 
Hepatic effects of dermatological drugs
Hepatic effects of dermatological drugsHepatic effects of dermatological drugs
Hepatic effects of dermatological drugsHossam Ghoneim
 
biotransformation
 biotransformation  biotransformation
biotransformation zeelmevada
 
Biotransformation (metabolism) of drugs
Biotransformation (metabolism) of drugsBiotransformation (metabolism) of drugs
Biotransformation (metabolism) of drugsZaigham Hammad
 
4.drug metabolism ns_15
4.drug metabolism ns_154.drug metabolism ns_15
4.drug metabolism ns_15amiomondalomi
 
Metabolic_Changes_of_Drugs_and_Related_Organic_Compounds.pptx
Metabolic_Changes_of_Drugs_and_Related_Organic_Compounds.pptxMetabolic_Changes_of_Drugs_and_Related_Organic_Compounds.pptx
Metabolic_Changes_of_Drugs_and_Related_Organic_Compounds.pptxThisiskarbin
 
Microsomal enzyme induction
Microsomal enzyme inductionMicrosomal enzyme induction
Microsomal enzyme inductionDrRenuYadav2
 
Metabolism and Excretion.pptx
Metabolism and Excretion.pptxMetabolism and Excretion.pptx
Metabolism and Excretion.pptxchetanadakhare
 
Polymorphism affecting Drug Metabolism.pptx
Polymorphism affecting Drug Metabolism.pptxPolymorphism affecting Drug Metabolism.pptx
Polymorphism affecting Drug Metabolism.pptxAnagha R Anil
 
Drugs and Genes - Pharmacogenomics
Drugs and Genes - Pharmacogenomics Drugs and Genes - Pharmacogenomics
Drugs and Genes - Pharmacogenomics Subhasree Pal
 

Similar to CYP450 Xenobiotics Metabolism (20)

Pharmacokinetics metabolism and excretion
Pharmacokinetics metabolism and excretionPharmacokinetics metabolism and excretion
Pharmacokinetics metabolism and excretion
 
Metabolism and excretion
Metabolism and excretionMetabolism and excretion
Metabolism and excretion
 
Xenobiotics aug 2013
Xenobiotics aug 2013Xenobiotics aug 2013
Xenobiotics aug 2013
 
Biotransfermation of drugs by harsha
Biotransfermation of drugs by harshaBiotransfermation of drugs by harsha
Biotransfermation of drugs by harsha
 
metabolism and elemination.ppt
metabolism and elemination.pptmetabolism and elemination.ppt
metabolism and elemination.ppt
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 
Cytochrome p450
Cytochrome p450Cytochrome p450
Cytochrome p450
 
Hepatic effects of dermatological drugs
Hepatic effects of dermatological drugsHepatic effects of dermatological drugs
Hepatic effects of dermatological drugs
 
biotransformation
 biotransformation  biotransformation
biotransformation
 
Biotransformation (metabolism) of drugs
Biotransformation (metabolism) of drugsBiotransformation (metabolism) of drugs
Biotransformation (metabolism) of drugs
 
Translocation of toxicants
Translocation of toxicantsTranslocation of toxicants
Translocation of toxicants
 
Kimia Medisinal_ADME
Kimia Medisinal_ADMEKimia Medisinal_ADME
Kimia Medisinal_ADME
 
4.drug metabolism ns_15
4.drug metabolism ns_154.drug metabolism ns_15
4.drug metabolism ns_15
 
Metabolic_Changes_of_Drugs_and_Related_Organic_Compounds.pptx
Metabolic_Changes_of_Drugs_and_Related_Organic_Compounds.pptxMetabolic_Changes_of_Drugs_and_Related_Organic_Compounds.pptx
Metabolic_Changes_of_Drugs_and_Related_Organic_Compounds.pptx
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Microsomal enzyme induction
Microsomal enzyme inductionMicrosomal enzyme induction
Microsomal enzyme induction
 
Metabolism and Excretion.pptx
Metabolism and Excretion.pptxMetabolism and Excretion.pptx
Metabolism and Excretion.pptx
 
Polymorphism affecting Drug Metabolism.pptx
Polymorphism affecting Drug Metabolism.pptxPolymorphism affecting Drug Metabolism.pptx
Polymorphism affecting Drug Metabolism.pptx
 
Drugs and Genes - Pharmacogenomics
Drugs and Genes - Pharmacogenomics Drugs and Genes - Pharmacogenomics
Drugs and Genes - Pharmacogenomics
 
Cytochrome p450
Cytochrome p450Cytochrome p450
Cytochrome p450
 

Recently uploaded

PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...saminamagar
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 

Recently uploaded (20)

PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 

CYP450 Xenobiotics Metabolism

  • 1. Xenobiotics Metabolism CYP450 Dr. Rajender Kumar P.G. Biochemistry Pt. B.D.S.P.G.I.M.S. Rohtak
  • 2. Introduction  A xenobiotic is a foreign chemical substance found within an organism that is not normally, naturally produced by or expected to be present within that organism. It can also cover substances which are present in much higher concentrations than are usual  Examples- Drugs, food additives, pollutants, insecticides, chemical carcinogens etc  They enter body mainly with food or as medications  Three principal entries: intestine, lungs, skin
  • 3. Entry of xenobiotic into cells • Simple diffusion – lipophilic substances, depends on concetration gradient (liver – freely permeable, big pores in cell membrane, most affected in poisoning) • Facilitated diffusion – transporters • Active transport – primary, secondary • Endocytosis • xenobiotics structurally similar with physiological substrates can utilize all available transport systems
  • 4. Excretion of xenobiotics from cell • primary active transport – needs energy: ATP hydrolysis • special ATP-ases called ABC (ATP binding cassettes) localized in cell membranes, export xenobiotics from cells into ECF • MRP (multidrug resistance proteins) – in increased expresion, they cause the resistance towards medicines
  • 5. Excretion of xenobiotics from body • chemically modified (more polar) xenobiotics are excreted by urine, bile, stool, or sweat • volatile substance by lungs • excretion into human milk • intestinal deconjugation and reabsorption sometimes occur - enterohepatic circulation
  • 6. Biotransformation and detoxification Biotransformation is Conversion of lipophilic to water- soluble chemicals catalyzed by enzymes in the liver and other tissues  In most cases, biotransformation lessens the toxicity of xenobiotics The term “detoxification” is sometimes used for many of the reactions involved in the metabolism of xenobiotics
  • 7. Increasingly humans are subjected to exposure to various foreign chemicals xenobiotics. Knowledge of the metabolism of xenobiotics is basic to a rational understanding of  pharmacology and therapeutics  pharmacy  toxicology  management of cancer, and drug addiction All these areas involve administration of, or exposure to, xenobiotics Biomedical importance
  • 8. 1. facilitates excretion: Converts lipophilic to hydrophilic compounds 2. Detoxification/inactivation: converts chemicals to less toxic forms 3. Metabolic activation: converts chemicals to more toxic active forms or converts inactive drug to its active form Purpose of Biotransformation
  • 9. Sites of biotransformation • Liver – Primary site! Rich in enzymes – Acts on endogenous and exogenous compounds • Extrahepatic metabolism sites – Intestinal wall • Sulfate conjugation • Esterase and lipases - important in prodrug metabolism – Lungs, kidney, placenta, brain, skin, adrenal glands
  • 10. Metabolism of Xenobiotics phase 1 1. Hydroxylation Monooxygenases or cytochrome P450s Hydroxylation may terminate the action of a drug 2. deamination, dehalogenation, desulfuration, epoxidation, peroxygenation, and reduction, hydrolysis • Purpose – Introduction of polar functional groups in a molecules ♣ Increase a molecule’s polarity ♣ Does provide a site for phase II metabolism
  • 11. Metabolism of Xenobiotics Phase 2 conjugation with glucuronic acid, sulfate, acetate, glutathione, methyl or certain amino acids, The overall purpose of phases II of metabolism of xenobiotics is to increase their water solubility (polarity) and thus excretion from the body
  • 12. Xenobiotic-Metabolizing Enzymes (XME) Phase 1 • Cytochromes P450 • Flavin Containing Monooxygenase • Epoxide Hydrolase • Alcohol /Aldehyde Dehydrogenases • Monoamine Oxidases • Xanthine oxidase Phase 2 “Transferases” Sulfotransferases (ST) UDP-glucuronosyltransferases (UGT) Glutathione S-transferases (GST)
  • 13. Cytochrome P450 • superfamily of heme enzymes (many isoforms) can catalyze different reaction types, mainly hydroxylation • Human:18 families, 43 subfamilies, 57 sequenced genes • can be induced and inhibited • occur in most tissues (except of muscles and erythrocytes) • the highest amount in the liver (ER) • exhibit genetic polymorphism (atypical biotransformations) • Nomencleature: CYP1A2 family subfamily individual member of that subfamily
  • 15.
  • 16.
  • 17. • They are present in highest amount in liver and small intestine but are probably present in all tissues • In liver and most other tissues, they are present mainly in the membranes of the smooth endoplasmic reticulum • In the adrenal, they are found in mitochondria as well as in the endoplasmic reticulum • The various hydroxylases present in that organ play an important role in cholesterol and steroid biosynthesis Cytochrome P450
  • 18. • At least six isoforms of cytochrome P450 are present in the endoplasmic reticulum of human liver, • acting on both xenobiotics and endogenous compounds • P450 metabolizes certain widely used solvents and also components found in tobacco smoke, many of which are established carcinogens • Most isoforms of cytochrome P450 are inducible • Induction of cytochrome P450 has important clinical implications, since it is a biochemical mechanism of drug interaction Cytochrome P450
  • 19. Certain isoforms of cytochrome P450 (eg, CYP1A1) are particularly involved in the metabolism of polycyclic aromatic hydrocarbons (PAHs) and related molecules for this reason they were formerly called aromatic hydrocarbon hydroxylases (AHHs) This enzyme is important in the metabolism of PAHs and in carcinogenesis produced by these agents Cytochrome P450
  • 20.
  • 21. Certain cytochrome P450s exist in polymorphic forms (genetic isoforms), some of which exhibit low catalytic activity CYP2A6 involved in the metabolism of nicotine to conitine, three alleles have been identified, a wild type and two null or inactive alleles Individuals with the null alleles, who have impaired metabolism of nicotine, are apparently protected against becoming tobacco- dependent smokers because their blood and brain concentrations of nicotine remain elevated longer It has been speculated that inhibiting CYP2A6 may be a novel way to help prevent and to treat smoking Cytochrome P450
  • 22. • some xenobiotics induce the synthesis of CYP – the metabolic capacity of CYP is enhanced • if administered inducer + drug, both metabolized by the same CYP isoform and drug is metabolized faster, drug is less effective • some xenobiotics inhibit CYP • the most common isoform CYP3A4 metabolizes more than 120 different pharmaceutical drugs • inhibitors of CYP3A4 are e.g. macrolide antibiotics, grapefruit (furanocoumarins), ketoconazole • if administered inhibitor + drug, increased drug level, overdosing , side effects Inducers and inhibitors of CYP450
  • 23. cytochrome P450 contains three cofactors and two enzymes: • NADPH+H+, FAD, heme • NADPH:CYP reductase (separates 2 H  2 e- + 2H+) and cytochrome P-450 hydroxylase Lipids are also components of the cytochrome P450 system The preferred lipid is phosphatidylcholine, which is the major lipid found in membranes of the endoplasmic reticulum Components of cytochrome P450
  • 24. Mechanism of CYP hydroxylation The formation of hydroxyl group  monooxygenase: one O atom from O2 molecule is incorporated into substrate between C and H (R-H → R-OH )  The second O atom + 2H from NADPH+H+ give water R-H + O2 + NADPH + H+ → R-OH + H2O + NADP+ 2 e- + 2 H+
  • 25. Mechanism of CYP hydroxylation
  • 27. • Hydroxylation is the chief reaction involved • The responsible enzymes are called monooxygenases and cytochrome P450s • Hydroxylation by CYP450 occurs in endogenous and exogenous substrates • Endoplasmic reticulum: squalene, cholesterol, bile acids, FA desaturation, prostaglandins, xenobiotics • Mitochondria: steroidal hormones hydroxylation
  • 29.
  • 30. Flavin-containing Monooxygenase •FAD-containing monooxygenases (FMO) oxidize nucleophilic nitrogen, sulfur and phosphorus heteroatoms of a variety of xenobiotics • FMO’s are not inducible and are constitutively expressed •Can be inhibited by other substrates • Located in microsomal fraction of liver, kidney, and lung FMO FAD FMO FADH2 NADP + FMO FADHOOH NADP+ FMO FADHOH NADP+ NADPH + H+ O2 X XO NADP+ H2O FADHOOH is 4a-hydroperoxyflavin FADHOH is 4a-hydroxyflavin FMO FAD
  • 32. Epoxides are highly reactive and mutagenic or carcinogenic can form during Phase I (CYP/COX) Epoxide hydrolase converting them into much less reactive dihydrodiols There are 5 distinct forms of EH in mammals: 1. Microsomal epoxide hydrolase (mEH) 2. Soluble epoxide hydrolase (sEH) 3. Cholesterol epoxide hydrolase 4. LTA4 hydrolase 5. Hepoxilin hydrolase mEH and sEH hydrolyze xenobiotic epoxides while the latter 3 hydrolases act on endogenous substrates Epoxides
  • 33. Hydrolysis in plasma by esterases (suxamethonium by cholinesterase) Alcohol and aldehyde dehydrogenase in liver cytosolic (ethanol) Monoamine oxidase in mitochondria (tyramine, noradrenaline, dopamine, amines) Xanthine oxidase (6-mercaptopurine, uric acid production) Enzymes for particular substrates (tyrosine hydroxylase, dopa-decarboxylase etc.) Other (non-microsomal) Phase I reactions
  • 34. RCH2NH2+O2+H2O2 RCHO+NH3+H2O •MAO catalyze the oxidative deamination of monoamines •Oxygen is used to remove an amine group from a molecule, resulting in the corresponding aldehyde and ammonia • MAO are found bound to the outer membrane of mitochondria in most cell types in the body •They belong to protein family of flavin containing amine oxidoreductases Non-Microsomal Oxidation Reactions
  • 35. Hydrolytic Reactions R1 R2 Name Susceptibility to Hydrolysis C O Ester Highest C S Thioester O O Carbonate C N Amide O N Carbamate N N Ureide Lowest Naming carbonyl - heteroatom groups Hydrolyzes (adds water to) esters and amides and their isosteres Enzymes: Non-microsomal hydrolases however amide hydrolysis appears to be mediated by liver microsomal amidases, esterases, deacylases R1 C R2 O δ− δ+ O CH3 CO2H O OH CO2 H CH3 O OH ASA Acetylsalicylic Acid esterase
  • 37.
  • 38. Glucuronidation • most frequent conjugation reaction. • UDP-glucuronic acid (UDPGA) is the glucuronyl donor • UDP-glucuronyl transferases (UGT), present in both the endoplasmic reticulum(ER) and cytosol, are the catalysts • Molecules such as 2-acetylaminofluorene (a carcinogen), aniline, benzoic acid, meprobamate (a tranquilizer), phenol, and many steroids are excreted as glucuronides • The glucuronide may be attached to oxygen, nitrogen, or sulfur groups of the substrates
  • 40.
  • 41. Some alcohols, arylamines, and phenols are sulfated other biologic sulfation reactions are sulfation of steroids, glycosaminoglycans, glycolipids, and glycoproteins The sulfate donor is adenosine 3-phosphate-5- phosphosulfate (PAPS) Leads to inactive water-soluble metabolites Sulfation
  • 42. Glutathione (γ-glutamyl-cysteinylglycine) is a tripeptide consisting of glutamic acid, cysteine, and glycine It detoxify electrophilic chemicals Conjugation with Glutathione
  • 43. The glutamyl and glycinyl groups belonging to glutathione are removed by specific Enzymes acetyl group (donated by acetyl- CoA) is added to the amino group of the remaining cysteinyl moiety The resulting compound is a mercapturic acid, a conjugate of L acetylcysteine, which is then excreted in the urine Mechanism Conjugation with Glutathione
  • 44. Reaction catalyzed by acetyltransferases present in the cytosol of various tissues, particularly liver Important for drugs with primary amino groups The drug isoniazid, used in the treatment of tuberculosis, is subject to acetylation Acetylation does NOT increase water solubility Causes Detoxification or termination of drug activity Acetylation isoniazid
  • 45. A few xenobiotics are subject to methylation by methyltransferases S-adenosylmethionine is methyl donor Key for biosynthesis of many compounds Important in the inactivation of physiologically active biogenic amines  neurotransmitters norepinephrine, dopamine, serotonin, histamine Minor pathway in the metabolism of drugs Methylation does NOT increase water solubility Most methylated products are inactive Methylation
  • 46.
  • 47. • with glycine, taurine • xenobiotics with -COOH groups are the substrates • endogenous example: conjugated bile acids Approximately 76% of aspirin is metabolized through amino acid conjugation Salicyluric acid, the glycine conjugate of salicyclic acid, is the main metabolite of aspirin Conjugation with amino acids
  • 48. Peroxidases RH + O2 PHS R-OOH + X or XH PHS MOx LOx ROH + XO or X R-OOH + carcinogen PHS MOx LOx active carcinogen (ie. aflatoxin) 1. Prostaglandin H synthase (PHS, COX1,2) (brain, lung, kidney, GI tract, urinary bladder) 2. Myeloperoxidase (MOx) (leukocytes) 3. Lactoperoxidase (LOx) (mammary gland) Most oxidative biotransformations require reduced cofactors NADPH and NADH, except for peroxidases that couple the reduction of hydrogen peroxide and lipid hydroperoxides to the oxidation of other substrates called cooxidation
  • 49. Prostaglandin H synthase COOH arachidonic acid O2 + O2 O O COOH OOH PGG2 cyclooxygenase peroxidase X or 2XH XO or 2X + H2O O O COOH OH PGH2 prostacyclinthromboxane A2prostaglandins (PGD2, PGE2) PHS (COX) has two catalytic activities: 1. a cyclooxygenase (COX) that converts arachidonic acid to the cyclic endoperoxide- hydroperoxide PGG2) 2. a peroxidase (that converts the hydroperoxide to the corresponding alcohol PGH2) which can result in the oxidation of xenobiotics 3. COX-2 inhibitors include aspirin and ibuprofin PHS can bioactivate carcinogens such as β- napthylamine, a bladder carcinogen NH2 PHS NH DNA damage
  • 50.
  • 51.
  • 52.
  • 53.
  • 56. PAHs formed by: - incomplete combustion of organic matter such as coal, wood, oil, petrol and diesel - coke production, vehicle and aircraft exhaust - smoking cigarettes - charbroiled meats PAHs are also found in natural fuel deposits A few PAHs are used to produce medicine, dyes, plastics, & pesticides Natural sources of PAHs include volcanoes and natural fires Examples include Benzo(a)pyrene and Benzo(b)fluoranthene PAH in environment
  • 57. - radicals formed by pyrolysis of hydrocarbons between 500 and 800ºC in zone of flame with insufficient O2 - C1 and C2 fragments combine in reducing atmosphere to form condensed aromatics - on cooling, PAHs condense onto existing particles – their distribution reflects their differing thermodynamic stability in O2 deficient flame Mechanism of formation during combustion Source % Heating, power production 51 Industrial producers 20 Incineration & open burning 28 Vehicles 1 B(a)P in foodstuffs μg/kg Charcoal broiled steak 8 Margarine 1-36 Sausages 4-50 Roasted coffee 1-13 Toast 0.5
  • 58. PAHs effects •Some PAHs have been shown to be cancer causing •Chronic Bronchitis •Skin Problems •Allergies Fetus is at greater risk and susceptibility : •Growth retardation •Low birth weight •Small head circumference •Low IQ •Damage DNA •Disrupt endocrine systems, such as estrogen, thyroid, and steroids
  • 59. CYP/PHS O EH HO OH CYP/PHS HO OH O benzo[a]pyrene (+) benzo[a]pyrene 7,8-oxide (-) benzo[a]pyrene 7,8-dihydrodiol (+) benzo[a]pyrene 7,8-dihydrodiol-9,10-epoxide ULTIMATE CARCINOGEN HN N N NO HN DNA HO OH HO BaP-N2 -dG DNA adduct DNA GST/GSH OH GS inactive (excreted) O CYP/PHS OH OH inactive Phase II Phase II and excretion PAHs metabolites
  • 60. • The first reaction is an epoxidation. With benzo(a)pyrene, the product is the corresponding 7,8-epoxide that, in turn, is subject of epoxide hydrolases to form stereoisomeric dihydrodiols • These are converted further to the 7,8-dihydrodiol-9,10- epoxide. The terminal oxidase is cytochrome P-450 (CYP1A1). The diol epoxide can exist in 4 stereoisomeric forms of which the key carcinogenic product is benzo(a)pyrene-r-7,t-8-diol-t-9,10-epoxide • PAH epoxides can then be conjugated with GSH. This conjugation is regarded as a true detoxification reaction and is mediated by glutathione transferase (GSTM1) PAHs metabolites
  • 61. • The epoxides that are not conjugated with GSH are converted into phenols and diols. These PAH metabolites, however, are sometimes not sufficiently polar to be excreted and are therefore conjugated with glucuronic or sulfuric acids to enable excretion to occur • In addition to conjugation, the hydroxylated derivatives of PAHs may undergo a number of oxidation and hydroxylation reactions. These include the conversion of phenols to phenol-epoxides and subsequently to diphenols and triols, diols to tetrols and diol-epoxides, and triols to triolepoxides and pentols PAHs metabolites
  • 62. Aflatoxin Aflatoxins are naturally occurring mycotoxins that are produced by many species of Aspergillus, a fungus. They can be found on moldy peanuts, rice, corn and other crops. Aflatoxin B1 is the most potent liver carcinogen. Aspergillus fungus that procues aflatoxin Aspergillus fungus on corn
  • 63. O O O OO OCH3 * * isolated e- -rich double bond aflatoxin O O O OO OCH3 * * O ULTIMATE CARCINOGEN CYP/PHS DNA NHN N N O NH2 DNA O O O OO OCH3 HO GST/GSH O O O OO OCH3 * *GS OH EH inactive (excreted) O O O OO OCH3 * *HO OH * * AFB1 N7-DNA adduct * electrophilic some DNA activity Epoxide hydrolase can detoxify aflatoxin-epoxide from binding to DNA, but still has some mutagenic activity Aflatoxin metabolism
  • 64. N-Hydroxylation of AAF N-Hydroxylation of AAF is the first metabolic step towards the development of a carcinogenic agent
  • 65. Further Metabolism of N-HydroxyAAF Produces Cancer N-HydroxyAAF undergoes phase II metabolism to the ultimate carcingogen. The glucuronide pathway is also involved in carcinogenesis
  • 67. • during cigarette burning? • temperature about 900 o C • dried tobacco undergoes incomplete combustion • nicotine partly passes to smoke, partly decomposes • Nicotine: 0.9 mg/cig. • Tar: 11 mg/cig. Tobacco
  • 68. Cigarette smoke contains • free base of nicotine – binds to receptors in the brain • CO – binds to hemoglobin to give carbonylhemoglobin (tissue ischemia) • nitrogen oxides – may generate reactive radical species • polycyclic aromatic hydrocarbons (PAH)(pyrene, chrysene, benzo[a]pyrene …), main components of tar • they can attack and damage DNA, carcinogens • other substances (N2, CO2, HCN, CH4, esters …) Tobacco
  • 69.
  • 70. Toxic effects of xenobiotics 1. cell injury (cytotoxicity) 2. the reactive species of a xenobiotic may bind to a protein, altering its antigenicity. The xenobiotic is said to act as a hapten 3. reactions of activated species of chemical carcinogens with DNA are thought to be of great importance in chemical carcinogenesis
  • 71. Factors that influence metabolism of xenobiotics • Age – older people less efficient at metabolism • Sex – Linked to hormonal differences • Heredity – Genetic differences can influence amounts and efficiency of metabolic enzymes • Disease states – Liver, cardiac, kidney disease

Editor's Notes

  1. Primary active transporters most commonly use adenosine triphosphate (ATP) as an energy source for substrate transport. Secondary active transporters use the concentration gradient of another substance, such as protons or sodium ions, but also other ionic endogenous substances as energy sources to drive transport.
  2. Types of ATPases P-type (Ca and Na/K pumps) Asp phosphorylation 10 transmembrane domains F-type (Proton pumps) Multisubunit complexes Reversible ABC (ATP binding cassettes) Mechanism unknown
  3. Subcellular Locations of Metabolizing Enzymes ENDOPLASMIC RETICULUM (microsomes): the primary location (a) Phase I: cytochrome P450, flavin-containing monooxygenase, aldehydeoxidase, carboxylesterase, epoxide hydrolase, prostaglandin synthase, esterase. (b) Phase II uridine diphosphate-glucuronosyltransferase, glutathione S-transferase, amino acid conjugating enzymes. CYTOSOL : many water-soluble enzymes. (a) Phase I: alcohol dehydrogenase, aldehyde reductase, aldehyde dehydrogenase, epoxide hydrolase, esterase (b) Phase II: sulfotransferase, glutathione S-transferase, N-acetyl transferase, catechol 0-methyl transferase, amino acid conjugating enzymes MITOCHONDRIA (a) Phase I: monoamine oxidase, aldehyde dehydrogenase, cytochrome P450 (b) Phase II: N-acetyl transferase, amino acid conjugating enzymes LYSOSOMES :Phase I: peptidase. NUCLEUS: Phase II: uridine diphosphate-glucuronosyltransferase (nuclear membrane of enterocytes)
  4. An epoxide is a cyclic ether with three ring atoms. These rings approximately define an equilateral triangle, which makes it highly strained. The strained ring makes epoxides more reactive than other ethers. EH is inducible by 2-3 fold by: CYP inducers (PAH, TCCD) EH is inducible by 10-fold by antioxidants BHA, BHT
  5. Two MAOs have been identified: MAO–A and MAO–B. Equal amounts are found in the liver, but the brain contains primarily MAO–B MAO–A is found in the adrenergic nerve endings MAO–A shows preference for serotonin, catecholamines, and other monoamines with phenolic aromatic rings MAO–B prefers non–phenolic amines b–Phenylisopropylamines such as amphetamine and ephedrine are not metabolized by MAOs but are potent inhibitors of MAOs
  6. Glutathione – three functions • Reduction- antioxidant (glutathione peroxidase) • Conjugation -(glutathione transferase) • AA Transport into cells -(glutamyltransferase, GMT) A number of potentially toxic electrophilic xenobiotics (such as certain carcinogens) are conjugated to the nucleophilic GSH The enzymes catalyzing these reactions are called glutathione S transferases and are present in high amounts in liver cytosol and in lower amounts in other tissues
  7. Other metabolites of aspirin the acyl glucuronide conjugate of salicylic acid (salicylic acid glucuronide) the phenol glucuronide conjugate of salicylic acid (salicyl phenol glucuronide) the ring hydroxylated product of salicylic acid (gentisic acid) the ring hydroxylated product of the glycine conjugate (gentisuric acid
  8. Cancers associated with exposure to PAHs-containing mixtures are predominantly lung and skin cancers,following inhalation and dermal exposure, respectively. Bladder cancer has also been associated with exposure to PAHs in aluminium plants or when handling asphalt